Affiliation:
1. Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa
2. The Medical Oncology Centre of Rosebank, Johannesburg 2196, South Africa
Abstract
Aside from their key protective roles in hemostasis and innate immunity, platelets are now recognized as having multifaceted, adverse roles in the pathogenesis, progression and outcome of many types of human malignancy. The most consistent and compelling evidence in this context has been derived from the notable association of elevated circulating platelet counts with the onset and prognosis of various human malignancies, particularly lung cancer, which represents the primary focus of the current review. Key topics include an overview of the association of lung cancer with the circulating platelet count, as well as the mechanisms of platelet-mediated, pro-tumorigenic immunosuppression, particularly the role of transforming growth factor beta 1. These issues are followed by a discussion regarding the pro-tumorigenic role of platelet-derived microparticles (PMPs), the most abundant type of microparticles (MPs) in human blood. In this context, the presence of increased levels of PMPs in the blood of lung cancer patients has been associated with tumor growth, invasion, angiogenesis and metastasis, which correlate with disease progression and decreased survival times. The final section of the review addresses, firstly, the role of cancer-related platelet activation and thrombosis in the pathogenesis of secondary cardiovascular disorders and the associated mortality, particularly in lung cancer, which is second only to disease progression; secondly, the review addresses the potential role of antiplatelet agents in the adjunctive therapy of cancer.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference157 articles.
1. Cancer incidence following a high-normal platelet count: Cohort study using electronic healthcare records from English primary care;Mounce;Br. J. Gen. Pract.,2020
2. Analysis of platelet count and new cancer diagnosis over a 10-year period;Giannakeas;JAMA Netw. Open,2022
3. Giannakeas, V., Kotsopoulos, J., Brooks, J.D., Cheung, M.C., Rosella, L., Lipscombe, L., Akbari, M.R., Austin, P.C., and Narod, S.A. (2022). Platelet count and survival after cancer. Cancers, 14.
4. Platelets and cancer metastasis: A causal relationship?;Honn;Cancer Metastasis Rev.,1992
5. Platelets and cancer;Nash;Lancet Oncol.,2002